You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
西點藥業(301130.SZ):目前已獲得蛋白琥珀酸鐵等產品的《受理通知書》
格隆匯 03-05 15:04

格隆匯3月5日丨西點藥業(301130.SZ)在投資者互動平台表示,公司本次設立全資子公司系根據公司業務發展需要,符合公司戰略發展的規劃,有利於公司積極開拓市場,從而促進公司業務的發展。目前公司已獲得蛋白琥珀酸鐵、利培酮口崩片(0.5mg、2mg)、注射用鹽酸羅沙替丁醋酸酯、蛋白琥珀酸鐵口服溶液、枸櫞酸鈣等產品的《受理通知書》,公司將積極推進上述項目進展並對上述項目的後續進展情況及時履行信息披露義務。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account